Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Legendary skateboarder Tony Hawk is the new spokesman for Citizen's new smart watch. Cheddar News spoke with Hawk to discuss his new partnership and how the watch helps him with his wellness routine.
Higher prices due to inflation combined with higher interest rates are creating a perfect storm for consumers who use credit cards, according to a Bankrate.com report. Ted Rossman, senior industry analyst at Bankrate.com, joined Cheddar News to discuss the latest report and what consumers can do to avoid any potential issues.
Elon Musk claimed that artificial intelligence has the potential to cause 'civilization destruction.' The billionaire is currently planning to come out with an AI platform, TruthGPT.
